Treatment of Acute Ischemic Stroke or Intracranial Bleeding with tPA and Carbamylated Erythropoietin
AssigneeH. Lundbeck A/S
InventorsThomas Nikolaj Sager, Michael Chopp, Zheng Gang Zhang
Life of this patent
Estimating the term…
Abstract
The present invention relates a method for the treatment of intracranial bleeding comprising administration of a therapeutically effective amount of tPa and a therapeutically effective amount of carbamylated erythropoietin.
Claims13
1-8. (canceled)
A method for treatment of intracranial bleeding in a patient in the need thereof comprising administration of a therapeutically effective amount tPa and a therapeutically effective amount of CEPO.
The method according to claim 10, wherein the intracranial bleeding is due to treatment with tPa and/or due to an ischemic insult in the brain.
A pharmaceutical composition comprising a therapeutically effective amount of CEPO and tPa and a pharmaceutically acceptable carrier.
The pharmaceutical composition according to claim 16, wherein the carrier is a diluent, an adjuvant or an excipient.
(canceled)
20-26. (canceled)
Dependencies are inferred from the claim text.